ILEVRO (Alcon Laboratories, Inc.)
Welcome to the PulseAid listing for the ILEVRO drug offered from Alcon Laboratories, Inc.. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alcon Laboratories, Inc. |
| NON-PROPRIETARY NAME: | nepafenac |
| SUBSTANCE NAME: | NEPAFENAC |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-12-20 |
| END MARKETING DATE: | 0000-00-00 |
ILEVRO HUMAN PRESCRIPTION DRUG Details:
| Item Description | ILEVRO from Alcon Laboratories, Inc. |
| LABELER NAME: | Alcon Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3(mg/mL) |
| START MARKETING DATE: | 2012-12-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0065-1750_1f3c665f-405f-6d15-4d14-b60795a47145 |
| PRODUCT NDC: | 0065-1750 |
| APPLICATION NUMBER: | NDA203491 |
Other NEPAFENAC Pharmaceutical Manufacturers / Labelers:
